On January 16, 2019, Vland Biotech Group (SSE: Vland, stock code: 603739) held a listing ceremony on the Shanghai Stock Exchange (SSE).
Vland publicly issued 38.667 million shares at a price of 10.19 yuan per share. The total amount of funds raised from the new shares was 394 million yuan and the total equity after the issuance was 154.667 million shares. Vland is a group mainly engaging in the production, R&D and sales of enzymes, probiotics and animal health products. In 2017, the company achieved an operating income of 799 million yuan and a net profit of 92.5301 million yuan. Vland is located in Qingdao, China and is the first company listed on SSE in Shandong Province in 2019.